An infection with RSV is a cold-like nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies, so the new drug is expected to fill a critical need.
FILE - This illustration provided by AstraZeneca depicts packaging for its medication Beyfortus.
The drug, developed by AstraZeneca and Sanofi, is expected to be ready in the fall before the RSV season, typically November through March. In the U.S., about 58,000 children younger than 5 are hospitalized for RSV each year and several hundred die.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, heath advisers recommended Thursday.
Consulte Mais informação »
Babies should get new drug that prevents RSV, CDC panel saysInfants should get a new drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, health advisers recommended Thursday.
Consulte Mais informação »
Babies born in fall and winter should get RSV shots, CDC panel recommendsMany babies should get a shot soon after birth to protect them from RSV, or respiratory syncytial virus, a panel of the Centers for Disease Control and Prevention's outside advisers voted Thursday.
Consulte Mais informação »
GSK sues Pfizer in U.S. court for patent infringement over RSV vaccineBoth RSV vaccines were approved by the U.S. Food and Drug Administration for use in adults 60 and above.
Consulte Mais informação »
Vaccines for flu and RSV now available ahead of fall virus season | CNNWith the fall respiratory virus season just around the corner, major US pharmacy chains have begun rolling out flu and RSV vaccine appointments.
Consulte Mais informação »